Ticker Hub
MGTX — AI Analysis & Sentiment
3 recent AI-generated analyses for MGTX. Sentiment and confidence insights updated continuously.
MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares
MeiraGTx's $100 million share offering will fund critical operations but significantly dilutes existing shareholders, creating a short-term bearish...
Apr 16, 2026MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
MeiraGTx's acquisition of bota-vec, a late-stage asset for XLRP with positive Phase 3 data, positions the company for significant commercial upside...
Apr 16, 2026MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results
MeiraGTx's recent FDA Breakthrough Therapy Designation for AAV2-hAQP1 and substantial non-dilutive funding from collaborations significantly de-ris...
Mar 26, 2026